Search Results - "Milger, K."

Assessing health-related quality of life in patients with interstitial lung diseases by Stoltefuß, S, Leuschner, G, Milger, K, Kauke, T, Götschke, J, Veit, T, Lenoir, A, Kneidinger, N, Behr, Jürgen

“…The R-Scale-PF was proposed to evaluate the health-related quality of life (HRQoL) in patients with idiopathic pulmonary fibrosis (IPF). We generated a German…”
Get full text

Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach by Milger, K., Götschke, J., Krause, L., Nathan, P., Alessandrini, F., Tufman, A., Fischer, R., Bartel, S., Theis, F. J., Behr, J., Dehmel, S., Mueller, N. S., Kneidinger, N., Krauss‐Etschmann, S.

“…Background Asthma is a heterogeneous chronic disease with different phenotypes and treatment responses. Thus, there is a high clinical need for molecular…”
Get full text

Bronchodilator Reversibility in the GAN Severe Asthma Cohort by Milger, K, Skowasch, D, Hamelmann, E, Mümmler, C, Idzko, M, Gappa, M, Jandl, M, Körner-Rettberg, C, Ehmann, R, Schmidt, O, Taube, C, Holtdirk, A, Timmermann, H, Buhl, R, Korn, S

“…Positive bronchodilator reversibility (BDR) is a diagnostic criterion for asthma. However, patients with asthma may exhibit a negative BDR response. Aim: To…”
Get full text

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany by Bergmann, Karl-Christian, Skowasch, Dirk, Timmermann, Hartmut, Lindner, Robert, Virchow, Johann Christian, Schmidt, Olaf, Koschel, Dirk, Neurohr, Claus, Heck, Sebastian, Milger, Katrin

“…Purpose: Asthma is one of the most prevalent chronic diseases in Germany affecting 4-5% of all adults and 10% of children. Despite the availability of…”
Get full text

P290SPECT myocardial perfusion imaging using regadenoson in end-stage lung disease: clearing the air and giving an answer by Schiopu, S, Zacherl, M, Todica, A, Milger, K, Behr, J, Neurohr, C, Huber, B, Kneidinger, N

Get full text

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma by Drick, Nora, Milger, Katrin, Seeliger, Benjamin, Fuge, Jan, Korn, Stephanie, Buhl, Roland, Schuhmann, Maren, Herth, Felix, Kendziora, Benjamin, Behr, Juergen, Kneidinger, Nikolaus, Bergmann, Karl-Christian, Taube, Christian, Welte, Tobias, Suhling, Hendrik

“…Anti-IL-5 antibodies represent an established therapy for severe eosinophilic asthma (SEA), but some patients show inadequate response. The objective of this…”
Get full text

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months by Kayser, Moritz Z, Drick, Nora, Milger, Katrin, Fuge, Jan, Kneidinger, Nikolaus, Korn, Stephanie, Buhl, Roland, Behr, Jurgen, Welte, Tobias, Suhling, Hendrik

“…Purpose: Treatment of severe eosinophilic asthma (SEA) has been revolutionized by the development of monoclonal antibodies targeting underlying immunological…”
Get full text

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study) by Korn, Stephanie, Milger, Katrin, Skowasch, Dirk, Schulz, Christian, Mohrlang, Cordula, Wernitz, Martin, Paulsson, Thomas, Hennig, Michael, Buhl, Roland

“…The German Asthma Net (GAN) operates a Severe Asthma Registry that provides an overview of the clinical presentation and management of patients with severe…”
Get full text

Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019 by Milger, Katrin, Koschel, Dirk, Skowasch, Dirk, Timmermann, Hartmut, Schmidt, Olaf, Bergmann, Karl-Christian, Neurohr, Claus, Lindner, Robert, Heck, Sebastian, Virchow, Johann

“…Asthma is affecting 4-5% of all adults (10% of children) in Germany, ≥ half are inadequately controlled. In 2019 up to 54 thousand patients suffered from…”
Get full text

C37 PULMONARY FIBROSIS: Insights From A Multi-Centre Real Life Experience In Germany With Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis by Bonella, F, Kreuter, M, Hagmeyer, L, Neurohr, C, Keller, C, Kohlhaeufl, M, Müller-Quernheim, J, Milger, K, Prasse, A

Get full text

Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis by Mümmler, Carlo, Mertsch, Pontus, Barnikel, Michaela, Haubner, Frank, Schönermarck, Ulf, Grabmaier, Ulrich, Schulze-Koops, Hendrik, Behr, Jürgen, Kneidinger, Nikolaus, Milger, Katrin

“…Benralizumab reduces exacerbations and long-term oral glucocorticosteroid (OCS) exposure in patients with severe eosinophilic asthma. In patients with…”
Get full text

Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany - Three Cases with Learnings in the Era of Anti- IL5 Treatments by Barnikel, Michaela, Grabmaier, Ulrich, Mertsch, Pontus, Ceelen, Felix, Janke, Christian, Behr, Jürgen, Kneidinger, Nikolaus, Milger, Katrin

“…Eosinophilic inflammation is a hallmark of asthma, and blood eosinophilia has been established as a biomarker for phenotyping asthma and predicting the…”
Get full text

Identification of a plasma mi RNA biomarker signature for allergic asthma: A translational approach by Milger, K., Götschke, J., Krause, L., Nathan, P., Alessandrini, F., Tufman, A., Fischer, R., Bartel, S., Theis, F. J., Behr, J., Dehmel, S., Mueller, N. S., Kneidinger, N., Krauss‐Etschmann, S.

“…Abstract Background Asthma is a heterogeneous chronic disease with different phenotypes and treatment responses. Thus, there is a high clinical need for…”
Get full text

Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany by Timmermann, Hartmut, Milger, Katrin, Virchow, Johann Christian, Schmidt, Olaf, Bergmann, Karl-Christian, Koschel, Dirk, Neurohr, Claus, Scholz, Florian, Heck, Sebastian, Skowasch, Dirk

“…It has been estimated that, in 2019, 54,000 patients in Germany had uncontrolled GINA step 4/5 asthma. In the current study we analyzed which health care…”
Get full text

A101 LYMPHOID CELLS AND LUNG INFLAMMATION: The Role Of Ccr2+ Cd4 T Cells In Lung Fibrosis by Milger, K, Yu, Y, Brudy, E, Irmler, M, Skapenko, A, Mayinger, M, Konigshoff, M, Eickelberg, O, Krauss-Etschmann, S

Get full text

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism by Milger, Katrin, Holdt, Lesca Miriam, Teupser, Daniel, Huber, Rudolf Maria, Behr, Jürgen, Kneidinger, Nikolaus

“…Deficiency in the serine protease inhibitor, alpha-1 antitrypsin (AAT), is known to cause emphysema and liver disease. Other manifestations, including airway…”
Get full text

Identification of a novel SERPINA-1mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism by Milger, K, Holdt, L, Teupser, D, Huber, R M, Behr, J, Kneidinger, N

“…Deficiency in the serine protease inhibitor, alpha-1 antitrypsin (AAT), is known to cause emphysema and liver disease. Other manifestations, including airway…”
Get full text

EARLY AND SUSTAINED ASTHMA CONTROL OVER 24 WEEKS AFTER TEZEPELUMAB INITIATION: REAL-WORLD ASCENT STUDY by Milger-Kneidinger, K., Gessner, C., Dorscheid, D., LLanos, J., Nåtman, J., Emmanuel, B., Le, T., Stjepanovic, N.

“…Randomized controlled trials have demonstrated the efficacy of tezepelumab in patients with severe, uncontrolled asthma (SUA). This interim analysis of the…”
Get full text

Personalisierte Medizin bei pulmonaler Hypertonie by Milger-Kneidinger, K.

“…Zusammenfassung Die pulmonale Hypertonie ist eine heterogene Gruppe von Erkrankungen, welche über den erhöhten mittleren pulmonal-arteriellen Druck definiert…”
Get full text

The role of coronary artery disease in lung transplantation by Luesebrink, E, Gade, N, Seifert, P, Hoffmann, S, Barton, J, Veit, T, Irlbeck, M, Schneider, C, Hatz, R, Hagl, C, Massberg, S, Behr, J, Milger-Kneidinger, K, Orban, M, Kneidinger, N

“…Abstract Background Coronary artery disease (CAD) is a common comorbidity in patients suffering from terminal lung disease and a recurrent problem in…”
Get full text